Gene · 11096
Papers3,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of miR-96-5p alleviates intervertebral disc degeneration by regulating the peroxisome proliferator-activated receptor γ/nuclear factor-kappaB pathway. | J Orthop Surg Res | 2023 | 38041147 | PubTator, text mining | PubMed |
| Exosomes from M2c macrophages alleviate intervertebral disc degeneration by promoting synthesis of the extracellular matrix via MiR-124/CILP/TGF-β. | Bioeng Transl Med | 2023 | 38023721 | PubTator, text mining | PubMed |
| Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 38022729 | PubTator, text mining | PubMed |
| Allogenic Platelet-Rich Plasma for the Treatment of Adhesive Capsulitis. | Cureus | 2023 | 38022351 | PubTator, text mining | PubMed |
| The antioxidant Glycitin protects against intervertebral disc degeneration through antagonizing inflammation and oxidative stress in nucleus pulposus cells. | Aging (Albany NY) | 2023 | 38019477 | PubTator, text mining | PubMed |
| Role of arachidonic acid metabolism in intervertebral disc degeneration: identification of potential biomarkers and therapeutic targets via multi-omics analysis and artificial intelligence strategies. | Lipids Health Dis | 2023 | 38007425 | PubTator, text mining | PubMed |
| Inflammatory and Metabolic Signaling Interfaces of the Hypertrophic and Senescent Chondrocyte Phenotypes Associated with Osteoarthritis. | Int J Mol Sci | 2023 | 38003658 | PubTator, text mining | PubMed |
| Carnosine, Zinc and Copper: A Menage a Trois in Bone and Cartilage Protection. | Int J Mol Sci | 2023 | 38003398 | PubTator, text mining | PubMed |
| The Dual Role of Small Extracellular Vesicles in Joint Osteoarthritis: Their Global and Non-Coding Regulatory RNA Molecule-Based Pathogenic and Therapeutic Effects. | Biomolecules | 2023 | 38002288 | PubTator, text mining | PubMed |
| Advanced Hydrogel-Based Strategies for Enhanced Bone and Cartilage Regeneration: A Comprehensive Review. | Gels | 2023 | 37998975 | PubTator, text mining | PubMed |
| Circ_0020014 mediates CTSB expression and participates in IL-1β-prompted chondrocyte injury via interacting with miR-24-3p. | J Orthop Surg Res | 2023 | 37980493 | PubTator, text mining | PubMed |
| Continuous detrimental activity of intra-articular fibrous scar tissue in correlation with posttraumatic ankle osteoarthritis. | Sci Rep | 2023 | 37973826 | PubTator, text mining | PubMed |
| Xanthohumol alleviates palmitate-induced inflammation and prevents osteoarthritis progression by attenuating mitochondria dysfunction/NLRP3 inflammasome axis. | Heliyon | 2023 | 37964828 | PubTator, text mining | PubMed |
| The potential role of synovial cells in the progression and treatment of osteoarthritis. | Exploration (Beijing) | 2023 | 37933282 | PubTator, text mining | PubMed |
| Strontium Ranelate Ameliorates Intervertebral Disc Degeneration via Regulating TGF-β1/NF-κB Axis. | Int J Med Sci | 2023 | 37928874 | PubTator, text mining | PubMed |
| Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker. | Front Immunol | 2023 | 37915565 | PubTator, text mining | PubMed |
| Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4). | Pharmaceuticals (Basel) | 2023 | 37895896 | PubTator, text mining | PubMed |
| Understanding Intervertebral Disc Degeneration: Background Factors and the Role of Initial Injury. | Biomedicines | 2023 | 37893088 | PubTator, text mining | PubMed |
| [Salvianolic acid A contributes to cartilage endplate cell restoration by regulating miR-940 and miR-576-5p]. | Zhongguo Gu Shang | 2023 | 37881933 | PubTator, text mining | PubMed |
| The emerging potential of siRNA nanotherapeutics in treatment of arthritis. | Asian J Pharm Sci | 2023 | 37881798 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11096/papers?page=15